This DTI Global Watch Mission reviewed Nanomedicine technologies for application in Diagnostics and Pharma and Healthcare applications with specific focus on Diagnostics, Drug discovery & delivery and Medical devices in Japan. Japan has a global lead on nanotechnologies based in the electronics sector and are globally leading in the provision of technology platforms which will have impact on Nanomedicine. This is a different, but synergistic, approach compared to the UK which the mission sought to understand in more detail by visiting key clusters in Tokyo and Osaka.

The key objective was to assess research and technology that would help underpin the UK’s ability to commercialize and manufacture nanomedicine applications. A further objective was to evaluate potential instrumentation synergies, complementary with UK strengths in Pharma & Biotech sectors. The mission also focused on the Japanese approach to convergence of nanotechnologies and healthcare.

Other speakers include:
> Dr Giles Sanders, Senior Consultant, TTP
> Professor John Ryan, Bionanotechnology IRC Director, University of Oxford
> Stephen Dennison, Project Manager, UK MNT Network

Registration required:

Yes

Free:

Yes